Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$3.25B |
| 2 |
Broadcom
AVGO
|
+$1.15B |
| 3 |
Netflix
NFLX
|
+$1.1B |
| 4 |
Truist Financial
TFC
|
+$1.07B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.07B |
Top Sells
| 1 |
Intel
INTC
|
+$1.46B |
| 2 |
UnitedHealth
UNH
|
+$1.38B |
| 3 |
Coca-Cola
KO
|
+$1.24B |
| 4 |
Merck
MRK
|
+$905M |
| 5 |
Fiserv
FI
|
+$904M |
Sector Composition
| 1 | Technology | 20.93% |
| 2 | Healthcare | 18.46% |
| 3 | Communication Services | 14.42% |
| 4 | Financials | 11.83% |
| 5 | Industrials | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Carnival Corp
CCL
$41.8B
| $41.1M | 0.02% |
3,119,942
-2,126,447
| -41% | -$28M |
|
277
BCE
BCE
$21.8B
| $40.9M | 0.02% |
1,001,925
| – | – |
|
278
Upwork
UPWK
$2.25B
| $40.9M | 0.02% |
6,345,736
+3,137,000
| +98% | +$20.2M |
|
279
Trinity Industries
TRN
$2.26B
| $40.8M | 0.02% |
2,535,886
+2,186,086
| +625% | +$35.1M |
|
280
Arcosa
ACA
$4.58B
| $40.3M | 0.02% |
1,013,000
+136,800
| +16% | +$5.44M |
|
281
DexCom
DXCM
$30.1B
| $39.7M | 0.02% |
+590,268
| New | +$39.7M |
|
|
BLUE
282
DELISTED
bluebird bio
BLUE
| $39.5M | 0.02% |
66,409
-49,395
| -43% | -$29.4M |
|
283
Exxon Mobil
XOM
$489B
| $39.5M | 0.02% |
1,040,634
-10,440,535
| -91% | -$396M |
|
284
Cardinal Health
CAH
$35.8B
| $38.2M | 0.02% |
797,019
| – | – |
|
285
Vir Biotechnology
VIR
$682M
| $37.5M | 0.02% |
1,094,305
+111,005
| +11% | +$3.8M |
|
286
Mattel
MAT
$5.55B
| $34.7M | 0.01% |
3,941,175
| – | – |
|
287
Nucor
NUE
$32.9B
| $34.6M | 0.01% |
+960,152
| New | +$34.6M |
|
288
Globant
GLOB
$2.45B
| $34.5M | 0.01% |
392,531
+189,600
| +93% | +$16.7M |
|
|
KRTX
289
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $34.2M | 0.01% |
+474,600
| New | +$34.2M |
|
290
Elanco Animal Health
ELAN
$9.19B
| $33.6M | 0.01% |
1,501,355
| – | – |
|
291
Gossamer Bio
GOSS
$725M
| $33.3M | 0.01% |
3,275,851
| – | – |
|
292
Intuitive Surgical
ISRG
$155B
| $33M | 0.01% |
+200,157
| New | +$33M |
|
293
HDFC Bank
HDB
$180B
| $32.7M | 0.01% |
851,233
+762,252
| +857% | +$29.3M |
|
294
Kratos Defense & Security Solutions
KTOS
$12.3B
| $32.6M | 0.01% |
2,357,700
+650,000
| +38% | +$9M |
|
295
Franco-Nevada
FNV
$39.1B
| $32M | 0.01% |
+321,108
| New | +$32M |
|
296
C.H. Robinson
CHRW
$15.7B
| $30.8M | 0.01% |
464,816
| – | – |
|
297
Autodesk
ADSK
$67.6B
| $30.4M | 0.01% |
194,447
-83
| -0% | -$13K |
|
|
AYX
298
DELISTED
Alteryx, Inc.
AYX
| $30.3M | 0.01% |
318,263
-14,337
| -4% | -$1.36M |
|
299
Halliburton
HAL
$18.9B
| $28.2M | 0.01% |
4,110,643
-6,215,745
| -60% | -$42.6M |
|
300
Saia
SAIA
$8.57B
| $27.6M | 0.01% |
375,200
+262,600
| +233% | +$19.3M |
|